[1]CurrentPatentAssignee:ASTRAZENECAPLC-US2014/357661,2014,A1Locationinpatent:Paragraph0406-0409
[2]DeSavi,Chris;Bradbury,RobertH.;Rabow,AlfredA.;Norman,RichardA.;DeAlmeida,Camila;Andrews,DavidM.;Ballard,Peter;Buttar,David;Callis,RowenaJ.;Currie,GordonS.;Curwen,JonO.;Davies,ChrisD.;Donald,CraigS.;Feron,LymanJ.L.;Gingell,Helen;Glossop,StevenC.;Hayter,BarryR.;Hussain,Syeed;Karoutchi,Galith;Lamont,ScottG.;MacFaul,Philip;Moss,ThomasA.;Pearson,StuartE.;Tonge,Michael;Walker,GraemeE.;Weir,HazelM.;Wilson,Zena[JournalofMedicinalChemistry,2015,vol.58,#20,p.8128-8140]
[3]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2018/65501,2018,A1Locationinpatent:Page/Pagecolumn38;122
[1]CurrentPatentAssignee:ASTRAZENECAPLC-US2014/357661,2014,A1Locationinpatent:Paragraph0536-0538
[1]CurrentPatentAssignee:ASTRAZENECAPLC-US2014/357661,2014,A1Locationinpatent:Paragraph0538-0540
[1]CurrentPatentAssignee:ASTRAZENECAPLC-US2014/357661,2014,A1
[2]DeSavi,Chris;Bradbury,RobertH.;Rabow,AlfredA.;Norman,RichardA.;DeAlmeida,Camila;Andrews,DavidM.;Ballard,Peter;Buttar,David;Callis,RowenaJ.;Currie,GordonS.;Curwen,JonO.;Davies,ChrisD.;Donald,CraigS.;Feron,LymanJ.L.;Gingell,Helen;Glossop,StevenC.;Hayter,BarryR.;Hussain,Syeed;Karoutchi,Galith;Lamont,ScottG.;MacFaul,Philip;Moss,ThomasA.;Pearson,StuartE.;Tonge,Michael;Walker,GraemeE.;Weir,HazelM.;Wilson,Zena[JournalofMedicinalChemistry,2015,vol.58,#20,p.8128-8140]
[1]CurrentPatentAssignee:ASTRAZENECAPLC-US2014/357661,2014,A1
Title: Weir HM, et al. AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and ESR1-Mutant Breast Tumors in Preclinical Models. Cancer Res. 2016 Jun 1;76(11):3307-18.
Title: De Savi C, et al. Optimization of a Novel Binding Motif to (E)-3-(3,5-Difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido,4-bindol-1-yl)phenyl)acrylic Acid (AZD9496), a Potent and Orally Bioavailable Selective Estrogen Receptor Downregulator and Antagonist. J Med Chem. 2015 Oct 22;58(20):8128-40.
